{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0000", "char_start": 0, "char_end": 1200, "pages": [1], "text": "May 2020\nVolume 36 | Number 10\nBilling Reminder for Fee-for-Service Institutional Patient-Centered\nMedical Homes and Advanced Primary Care Program Providers\nThe following article provides a Medicaid fee-for-service (FFS) billing reminder to Article 28 clinics recognized\nunder either the Patient-Centered Medical Home (PCMH) or Advanced Primary Care (APC) Programs.\nBilling Reminder\nArticle 28 clinics are reminded that since PCMH- and APC-recognition is site specific, the Medicaid FFS\ninstitutional claim must include the United States Postal Service (USPS) ZIP+4 code of the recognized clinic's\nsite-specific physical location where services were rendered to the Medicaid member. The ZIP+4 code submitted\non the claim must reflect the actual service location where services were rendered, and not the ZIP+4 code\nassociated with the main facility or health system to which Medicaid payments are made.\nArticle 28 clinics are reminded to accurately code their FFS Medicaid claims with the following:\n• The National Provider Identifier (NPI) for both the PCMH- or APC-recognized clinic and the attending\nprimary care provider;\n• The appropriate Ambulatory Patient Group (APG) rate code; and\n• The corr", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0001", "char_start": 1050, "char_end": 2250, "pages": [1], "text": "the PCMH- or APC-recognized clinic and the attending\nprimary care provider;\n• The appropriate Ambulatory Patient Group (APG) rate code; and\n• The correct ZIP+4 code associated with the locator code where services were rendered to the Medicaid\nmember.\nNew System Edit on FFS PCMH and APC Claims\nA new system edit was implemented into the eMedNY claiming system as of January 23, 2020 for all Medicaid\nFFS institutional claims. This edit withholds the PCMH or APC incentive payment in situations where the ZIP+4\ncode submitted on the claim was not located on the provider’s rate file for the submitted rate code. The inability\nfor the eMedNY system to locate the submitted ZIP+4 code on the provider’s rate file causes the claim to trigger\nedit “02068” (Provider Rate Found Without Matching ZIP/Locator Code). The PCMH or APC incentive payment\nwill be withheld from any FFS institutional claim that triggers edit “02068”. The FFS institutional claim will still\nadjudicate as normal; however, the PCMH or APC incentive payment will be withheld. Providers are responsible\nfor reviewing their remit statements to ensure payment of the PCMH or APC incentive. Providers must resubmit\na claim adjustment to M", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0002", "char_start": 2100, "char_end": 3300, "pages": [1, 2], "text": "s are responsible\nfor reviewing their remit statements to ensure payment of the PCMH or APC incentive. Providers must resubmit\na claim adjustment to Medicaid with the correct ZIP+4 code that reflects the actual service location to be eligible\nto receive the incentive payment.\nQuestions and Additional Information:\n• Questions regarding Medicaid FFS incentive payments (including but not limited to missing incentive\npayments, claim add-on incentive payment amounts, and/or practice/provider recognition dates) should\nbe directed to: the eMedNY Call Center at (800) 343-9000 or via email at emednycallctr@csra.com.\n• Providers seeking assistance with FFS policy should contact the Office of Health Insurance Programs\n(OHIP) at (518) 473-2160.\n• Additional information can be found at: https://www.emedny.org/.\n\nAndrew M. Cuomo\nGovernor\nState of New York\nHoward A. Zucker, M.D., J.D.\nCommissioner\nNew York State\nDepartment of Health\nDonna Frescatore\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nBilling Reminder for Fee-for-Service Patient-Centered Medical Homes and\nAdvanced Primary Care", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0003", "char_start": 3150, "char_end": 4350, "pages": [2], "text": " the New York State Department of Health.\nIn This Issue…\nBilling Reminder for Fee-for-Service Patient-Centered Medical Homes and\nAdvanced Primary Care Program Providers .................................................................................................................... Cover\nPolicy and Billing\nAttention Patient-Centered Medical Home and Advanced Primary Care Program Providers: Telehealth has Been\nAdded as an Acceptable Modality Eligible to Receive Incentive Payments During the COVID-19 State of Emergency ....... 3\nMedicaid Taxi/Livery Reimbursement Fee Reduction ............................................................................................................ 4\nMedicaid Eligibility for Pregnant Women and COVID-19 ........................................................................................................ 4\nNYS Medicaid Fee-for-Service Policy and Billing Guidance for crizanlizumab-tmca (ADAKVEO®),\nNew Coverage Criteria and “J” Code ...................................................................................................................................... 5\nUpdated Criteria for HCPCS Code \"A4670\" - Automatic Blood Pressure Monitor .....", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0004", "char_start": 4200, "char_end": 5400, "pages": [2, 3], "text": "................................................................... 5\nUpdated Criteria for HCPCS Code \"A4670\" - Automatic Blood Pressure Monitor ................................................................. 6\nPharmacy\nPharmacy Update on Dose Optimization Program ................................................................................................................. 7\nReminder: Substance Use Disorder Drug Treatment: Medicaid Managed Care and Fee-for-Service Coverage .................. 8\nAll Providers\nNew York Medicaid EHR Incentive Program .......................................................................................................................... 9\nProvider Directory......................................................................................................................................................... 11\nMay 2020 New York State Medicaid Update pg. 2\n\nPolicy and Billing\nAttention Patient-Centered Medical Home and Advanced Primary Care\nProgram Providers: Telehealth has Been Added as an Acceptable\nModality Eligible to Receive Incentive Payments\nDuring the COVID-19 State of Emergency\nThis guidance is no longer applicable.\nThe following article ", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0005", "char_start": 5250, "char_end": 6450, "pages": [3], "text": "e\nModality Eligible to Receive Incentive Payments\nDuring the COVID-19 State of Emergency\nThis guidance is no longer applicable.\nThe following article pertains to Medicaid fee-for-service (FFS) clinics and practitioners that have achieved recognition as\neither Patient-Centered Medical Homes (PCMH) by the National Committee for Quality Assurance (NCQA) or Advanced\nPrimary Care (APC) programs.\nThis guidance is effective for dates of service on or after March 1, 2020 and shall remain in effect for the\nremainder of the disaster emergency declared by Executive Order No. 202, or until the issuance of\nsubsequent guidance by the NYSDOH prior to the expiration of such state disaster emergency\ndeclaration.\nIn response to the COVID-19 State of Emergency, New York State (NYS) Medicaid broadly expanded the ability\nof Medicaid providers to use a wide variety of communication methods to deliver services remotely via telehealth\nwhere face-to-face visits may not be recommended, and it is appropriate for the member. For purposes of the\nState of Emergency, the definition of telehealth was expanded to include telephonic communications,\ntelemedicine, store and forward, and remote patient monitoring.\nThe", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0006", "char_start": 6300, "char_end": 7500, "pages": [3], "text": "y, the definition of telehealth was expanded to include telephonic communications,\ntelemedicine, store and forward, and remote patient monitoring.\nThe following temporary revisions have been implemented into the eMedNY claiming system to allow\nPCMH/APC-recognized clinics and practitioners billing FFS Medicaid for telehealth claims to be able to receive\nthe PCMH/APC incentive for those primary care or preventative medicine services that would have otherwise\nbeen rendered to the member face-to-face:\n• For practitioner claims:\nThe Place of Service (POS) “02” was added as an acceptable location to allow\npractitioners to receive the PCMH/APC incentive payment. POS “02” is the service\nlocation that is used to indicate that health services and health-related services are\nprovided via telemedicine, store-and-forward, and remote patient monitoring services.\nProviders must bill with POS code “02” and append the applicable modifier “95”, “GT”,\nor “GQ”. The code POS “02” is not used when billing for telephonic services.\nNote: Physicians, physician assistants and registered nurse practitioners that are included on the\nPCMH/APC recognized provider list that are billing for telephonic communicati", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0007", "char_start": 7350, "char_end": 8550, "pages": [3, 4], "text": "n assistants and registered nurse practitioners that are included on the\nPCMH/APC recognized provider list that are billing for telephonic communication services via Lane\n1 referenced in the May 1, 2020 Comprehensive Guidance Regarding Use of Telehealth including\nTelephonic Services During the COVID-19 State of Emergency should reflect the POS location\nwhere the service would have been rendered to the member face-to-face (e.g., office POS “11”.)\nThe Evaluation and Management (E&M) telephonic services procedure codes “99441”-\n“99443” referenced in Lane 1 of the May 1, 2020 Guidance referenced above were added\nas acceptable procedure codes that are eligible to receive incentive payments.\nThe procedure code for Remote Patient Monitoring (RPM) “99091” was added as an\nacceptable procedure code that is eligible to receive incentive payments.\nMay 2020 New York State Medicaid Update pg. 3\n\n• For institutional claims:\nThe telephonic service rate codes “4012”, “4015”, “7961”-“7962”, referenced in Lanes\n3, and 4 of the May 1, 2020 Guidance referenced above were added as acceptable rate\ncodes that are eligible to receive incentive payments.\nAny professional or institutional claims that were pr", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0008", "char_start": 8400, "char_end": 9600, "pages": [4], "text": "enced above were added as acceptable rate\ncodes that are eligible to receive incentive payments.\nAny professional or institutional claims that were previously adjudicated for dates of service on or after March 1,\n2020 that are eligible to receive an incentive payment based on the requirements referenced above will be\nsystematically identified, and automatically reprocessed within the eMedNY system to add the PCMH/APC\nincentive payment. Providers and institutions do not need to resubmit a claim adjustment to receive any missed\nincentive payments.\nThis guidance replaces any previously issued guidance or provider communications issued regarding payment\nof the PCMH/APC incentive on claims for telehealth and telephonic services rendered during the COVID-19\nState of Emergency. All other PCMH/APC policy and billing guidelines remain unchanged. Please refer to the\nNovember 2018 issue of the Medicaid Update for additional information.\nQuestions and Additional Information:\n• Questions regarding Medicaid FFS incentive payments (including but not limited to missing incentive\npayments, claim add-on incentive payment amounts, and/or practice/provider recognition dates) should\nbe directed to Comp", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0009", "char_start": 9450, "char_end": 10650, "pages": [4], "text": " limited to missing incentive\npayments, claim add-on incentive payment amounts, and/or practice/provider recognition dates) should\nbe directed to Computer Sciences Corporation (CSC a/k/a CSRA) at (800) 343-9000 or via email to\nemednycallctr@csra.com.\n• Additional information can also be found on the eMedNY website at: https://www.emedny.org/.\n• Providers seeking assistance with FFS Policy should contact pcmh@health.NY.gov.\n*******************************************************************************************************************\nMedicaid Taxi/Livery Reimbursement Fee Reduction\nThe Enacted 2020-2021 State Budget and Medicaid Redesign Team II (MRTII) initiative will decrease Medicaid\nTaxi/Livery base and mileage fees by 7.5 percent effective June 1, 2020. The updated fees effective for dates\nof service on or after June 1, 2020 are posted at: https://www.emedny.org/ProviderManuals/Transportation/\nindex.aspx.\nQuestions\nQuestions regarding this policy should be directed to the Office of Health Insurance Programs (OHIP), Bureau\nof Medicaid Transportation at (518) 473-2160 or medtrans@health.ny.gov.\n**********************************************************************************", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0010", "char_start": 10500, "char_end": 11700, "pages": [4, 5], "text": "edicaid Transportation at (518) 473-2160 or medtrans@health.ny.gov.\n*******************************************************************************************************************\nMedicaid Eligibility for Pregnant Women and COVID-19\nThis guidance is no longer applicable.\nDuring the period of the COVID-19 emergency, Medicaid coverage will be continued for anyone who had\nMedicaid coverage on March 18, 2020. This includes all pregnant women, regardless of their immigration\nstatus. This means a pregnant woman may have coverage beyond her typical 60-day post-partum period or her\ntypical twelve (12) months continuous Medicaid coverage period, depending on the duration of the disaster\nperiod.\nUnder ordinary circumstances many, if not most, pregnant women receive coverage beyond the 60-day post-\npartum period because they are eligible for twelve (12) months of continuous Medicaid coverage. Most Modified\nAdjusted Gross Income (MAGI) consumers receive twelve (12) months of Medicaid coverage from their eligibility\ndetermination or redetermination, regardless of changes in circumstance.\nMay 2020 New York State Medicaid Update pg. 4\n\nSome pregnant women are not eligible for twelve (12) mont", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0011", "char_start": 11550, "char_end": 12750, "pages": [4, 5], "text": "ation, regardless of changes in circumstance.\nMay 2020 New York State Medicaid Update pg. 4\n\nSome pregnant women are not eligible for twelve (12) months of continuous Medicaid coverage due to their\nimmigration status. These pregnant women are eligible to move to Essential Plan (EP) after their 60-day post-\npartum period. EP has a plan/provider overlap of approximately 97 percent, which ensures continuity of care for\nwomen who change programs. During the COVID-19 emergency period, pregnant women who would ordinarily\nmove to EP after their 60-day post-partum period will have continued Medicaid coverage. Eligibility\nredeterminations and any resulting program changes will take place after the emergency period is over.\n*******************************************************************************************************************\nNYS Medicaid Fee-for-Service Policy and Billing Guidance for\ncrizanlizumab-tmca (ADAKVEO®), New Coverage Criteria and “J” Code\nEffective July 1, 2020, New York State (NYS) Medicaid fee-for-service (FFS) will begin utilizing criteria to\ndetermine the approval of crizanlizumab-tmca (ADVAKVEO®) for members with sickle cell disease to reduce\nthe frequency of vas", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0012", "char_start": 12600, "char_end": 13800, "pages": [5], "text": "gin utilizing criteria to\ndetermine the approval of crizanlizumab-tmca (ADVAKVEO®) for members with sickle cell disease to reduce\nthe frequency of vasoocclusive crises when the member meets the criteria outlined in this policy. ADAKVEO®\nwas approved by the U.S. Food and Drug Administration (FDA) for use on November 15, 2019.\nNYS FFS Coverage Policy\nIn accordance with FDA indications, FFS will reimburse for ADVAKVEO® when the following criteria are met:\n• The patient must have a confirmed diagnosis of sickle cell disease\n• The patient must be sixteen (16) years of age and older\nFFS Billing:\n• Payment for the drug’s administration will be made through the outpatient Ambulatory Patient Groups\n(APG) payment when administered in a clinic setting.\n• Facilities administering ADVAKVEO® will be reimbursed for the cost of the drug using the ordered\nambulatory fee schedule. The ordered ambulatory claim should be submitted on paper (using the\neMedNY 150003 claim form) and should include the facility’s actual acquisition cost by invoice.\nDocumentation of medical necessity that includes the criteria listed above must accompany the\nclaim. Ordered ambulatory billing guidelines can be found at: htt", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0013", "char_start": 13650, "char_end": 14850, "pages": [5], "text": "tion of medical necessity that includes the criteria listed above must accompany the\nclaim. Ordered ambulatory billing guidelines can be found at: https://www.emedny.org/ProviderManuals\n/OrderedAmbulatory/PDFS/OrderedAmbulatory_Billing_Guidelines.pdf.\n• The following documentation must be included with the claim:\nManufacturer’s invoice showing the acquisition cost of the biologic, including all discounts, rebates\nor incentives;\nDocumentation of the medication administration; and\nDocumentation of the criteria listed under the NYS FFS Coverage Policy section above.\n• Healthcare Common Procedure Coding System (HCPCS) code “J0791” (injection, crizanlizumab-tmca,\n5mg) should be used to bill for “ADVAKVEO®”. The associated National Drug Code (NDC) must be\nincluded on the claim.\n• Actual reimbursement will be calculated based on the actual acquisition cost, per the submitted invoice.\nProviders should report actual acquisition cost in the allowed amount field. Reimbursement will be at the\nacquisition cost on the provider’s invoice.\n• Missing or incomplete documentation submissions will result in denials of the claim and delay the\nprocessing claims payment.\nReminders\nProviders are reminded ", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0014", "char_start": 14700, "char_end": 15900, "pages": [5, 6], "text": "or incomplete documentation submissions will result in denials of the claim and delay the\nprocessing claims payment.\nReminders\nProviders are reminded that any off-invoice discounts or rebates received from the manufacturer must be passed\nback to Medicaid. Storage and handling charges are included in the APG outpatient payment and will not be\nreimbursed separately.\nMedicaid Managed Care (MMC) Billing\nProviders participating in MMC should check with the individual health plans to determine their billing policies\nand how each MMC plan will apply this FFS policy.\nMay 2020 New York State Medicaid Update pg. 5\n\nQuestions:\n• FFS claim questions should be directed to the eMedNY call center at (800) 343-9000.\n• Additional FFS practitioner administered drug policies can be found at: https://www.health.ny.gov/health\n_care/medicaid/program/practitioner_administered/ffs_practitioner_administer.htm.\n• FFS policy and billing questions may be directed to the Office of Health Insurance Programs (OHIP),\nDivision of Program Development and Management at (518) 473-2160.\n• MMC reimbursement, billing, and/or documentation questions should be directed to the enrollee's MMC\nplan.\n*************************", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0015", "char_start": 15750, "char_end": 16950, "pages": [6], "text": " (518) 473-2160.\n• MMC reimbursement, billing, and/or documentation questions should be directed to the enrollee's MMC\nplan.\n*******************************************************************************************************************\nUpdated Criteria for HCPCS Code\n“A4670” - Automatic Blood Pressure Monitor\nEffective July 6, 2020, fee-for-service (FFS) coverage criteria and reimbursement for Healthcare Common\nProcedure Coding System (HCPCS) code “A4670” will be updated and may be dispensed without prior\napproval. The new coverage criteria will be as follows:\nCode Fee Max Unit/Frequency\nA4670 $50.00 1 every 5 years\n“A4670” - Automatic Blood Pressure Monitor Coverage Criteria:\n• The monitor must be ordered by a qualified practitioner as part of a comprehensive treatment plan\nthat requires member monitoring and recording of blood pressure readings in the home.\n• Replacement due to other factors not covered by the manufacturer’s warranty requires prior\napproval. Documentation of use and compliance to the physician treatment plan for monitoring\nblood pressure in the home must be submitted with the request.\nQuestions:\n• Questions regarding this guidance should be directed to (800)", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0016", "char_start": 16800, "char_end": 18000, "pages": [6, 7], "text": "r monitoring\nblood pressure in the home must be submitted with the request.\nQuestions:\n• Questions regarding this guidance should be directed to (800) 342-3005 or via email to\nOHIPMEDPA@health.ny.gov.\n• Medicaid Managed Care (MMC) questions regarding policy should be directed to the member’s MMC\nplan.\n*******************************************************************************************************************\nMay 2020 New York State Medicaid Update pg. 6\n\nPharmacy\nPharmacy Update on Dose Optimization Program\nEffective February 27, 2020, the New York State (NYS) Medicaid fee-for-service (FFS) program updated the\nDose Optimization initiative with the drugs listed below. Dose optimization can reduce prescription costs by\nreducing the number of pills a patient needs to take each day. The NYS Department of Health has identified\ndrugs to be included in this program, the majority of which have Food and Drug Administration (FDA) approval\nfor once-a-day dosing, have multiple strengths available in correlating increments at similar costs, and are\ncurrently being utilized above the recommended dosing frequency. Prior authorization (PA) is required to\nobtain the following medication beyo", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0017", "char_start": 17850, "char_end": 19050, "pages": [7], "text": " and are\ncurrently being utilized above the recommended dosing frequency. Prior authorization (PA) is required to\nobtain the following medication beyond the following limits:\nDOSE OPTIMIZATION CHART\nCARDIOVASCULAR AGENTS\nAntiarrhythmics\nDrug Name, Strength Dose Optimization Limitations\nIn case of dose titration for these medications, the\nDepartment will allow for multi-day dosing (up to 2\namiodarone 100mg 1 daily Tablet doses/daily) for loading dose for 30 days\nCENTRAL NERVOUS SYSTEM AGENTS\nAnticonvulsants\nDrug Name, Strength Dose Optimization Limitations\nAptiom® 200mg, 400mg 1 daily Tablet\nFycompa® 4mg, 6mg 1 daily Tablet\ntopiramate ER 100mg 1 daily Capsule\nIn case of dose titration for these medications, the\nDepartment will allow for multi-day dosing (up to 2\nLamictal XR® 50mg 1 daily Tablet doses/daily) for titration purposes for 90 days\nIn case of dose titration for these medications, the\nDepartment will allow for multi-day dosing (up to 2\nOxtellar XR® 300mg 1 daily Tablet doses/daily) for titration purposes for 90 days\nCentral Nervous System (CNS) Stimulants\nDrug Name, Strength Dose Optimization Limitations\nVyvanse® 10mg, 40mg 1 daily Capsule\nGASTROINTESTINAL AGENTS\nProton Pum", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0018", "char_start": 18900, "char_end": 20100, "pages": [7], "text": "rvous System (CNS) Stimulants\nDrug Name, Strength Dose Optimization Limitations\nVyvanse® 10mg, 40mg 1 daily Capsule\nGASTROINTESTINAL AGENTS\nProton Pump Inhibitors\nDrug Name, Strength Dose Optimization Limitations\nNexium® 10mg, 20mg 1 daily Packet\nHEMATOLOGIC AGENTS\nAnticoagulants – Oral\nDrug Name, Strength Dose Optimization Limitations\nXarelto® 10mg 1 daily Tablet\nPA requirements are not dependent on the date a prescription is written. New prescriptions and refills on existing\nprescriptions require PA even if the prescription was written before the date the drug was determined to require\na PA. To obtain a PA, providers may contact the Clinical Call Center at (877) 309-9493. The Clinical Call Center\nis available 24 hours per day, seven days per week and staffed with pharmacy technicians and pharmacists\navailable to assist providers in quickly obtaining a PA.\nCurrent information on the Medicaid FFS Pharmacy PA Programs, including the Dose Optimization initiative,\ncan be found at: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf. This document contains\na full list of drugs subject to the NYS Medicaid FFS Pharmacy Programs.\n*************************************************", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0019", "char_start": 19950, "char_end": 21150, "pages": [7, 8], "text": ".pdf. This document contains\na full list of drugs subject to the NYS Medicaid FFS Pharmacy Programs.\n*******************************************************************************************************************\nMay 2020 New York State Medicaid Update pg. 7\n\nReminder: Substance Use Disorder Drug Treatment:\nMedicaid Managed Care and Fee-for-Service Coverage\nImportant Legislation Regarding Drugs to Treat Substance Use Disorders:\n• Medicaid policy requires Medicaid fee-for-service (FFS) and Medicaid Managed Care (MMC) to provide\nat least five days’ coverage for emergencies, without prior authorization, for medications used to\ntreat substance use disorders. This includes medication associated with the management of opioid\nwithdrawal and/or stabilization as well as medication used for opioid overdose reversal.\n• As published in the August 2016 issue of the Medicaid Update, New York State Social Services Law\n§364-j and Public Health Law §273, prohibit prior authorization under Medicaid FFS and MMC for\ninitial or renewal prescriptions for preferred or formulary forms of buprenorphine or injectable\nnaltrexone when used for detoxification or maintenance treatment of opioid addiction. T", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0020", "char_start": 21000, "char_end": 22200, "pages": [8], "text": "or preferred or formulary forms of buprenorphine or injectable\nnaltrexone when used for detoxification or maintenance treatment of opioid addiction. The\nfrequency, quantity, and/or duration limits supported by the Food and Drug Administration (FDA) and\nCompendia may continue to be applied.\nPlan Contacts and Formulary Resource\nThe New York State MMC Pharmacy Benefit Information Center website contains information that can assist\nproviders in identifying which medications are included on the NYS MMC formularies. The NYS MMC Pharmacy\nBenefit Information Center can be found at: https://mmcdruginformation.nysdoh.suny.edu/.\nA comprehensive listing of Drugs to Treat Chemical Dependence, showing formulary coverage by plan, can be\nfound on the “DRUG QUICKLISTS” page of the NYS MMC Pharmacy Benefit Information Center by selecting\nthe “Therapeutic Classes, Other” tab. The list can be downloaded and printed.\nThe NYS MMC Pharmacy Benefit Information Center formulary coverage is updated quarterly. The website also\nincludes a link to each individual plans’ website, with their contact information and formulary, in order to access\nmore in-depth information about each plan.\nAdditional information on", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0021", "char_start": 22050, "char_end": 23250, "pages": [8], "text": " plans’ website, with their contact information and formulary, in order to access\nmore in-depth information about each plan.\nAdditional information on substance use disorder drug coverage in FFS is available within the New York State\nMedicaid FFS Preferred Drug List at: https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf.\nFrequently Asked Questions (FAQ):\nQ1. What if the pharmacy does not have the medication in stock or not enough medication in stock?\nA. The pharmacist can work with the prescriber to determine another pharmacy that has the medication in stock\nand send a new prescription to that pharmacy. If the pharmacy has limited stock, they can partially fill the\nprescription and dispense the remainder when the product is received according to applicable NYS law.\nQ2. What if the wholesaler is limiting the amount of medication a pharmacy can receive?\nA. Pharmacies should contact their wholesaler to determine if there is a shortage issue or a limit being imposed\non the product in question. If the wholesaler imposed a limit, the pharmacy can work with the wholesaler to\nincrease that limit. This may include providing additional information regarding their dispensing patter", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0022", "char_start": 23100, "char_end": 24300, "pages": [8, 9], "text": " the pharmacy can work with the wholesaler to\nincrease that limit. This may include providing additional information regarding their dispensing patterns.\nQ3. What if the generic product is not available and the brand product is available and in stock?\nA. The pharmacist can contact the insurance plan to authorize a pharmacy override to allow the brand medication\nto be dispensed when the generic is unavailable due to a marketplace shortage or when the product is\ntemporality unavailable.\n*******************************************************************************************************************\nMay 2020 New York State Medicaid Update pg. 8\n\nAll Providers\nNew York Medicaid EHR Incentive Program\nDistribution to Eligible Professionals & Eligible Hospitals Since the Start of the Program in 2011*\nNumber of Payments: Distributed Funds:\n43,558 $1,010,583,699\n*As of 5/22/2020\nThrough the New York (NY) Medicaid Electronic Health Record (EHR) Incentive Program, eligible professionals\n(EPs) and eligible hospitals (EHs) in New York who adopt, implement, or upgrade certified EHR technology\n(CEHRT) and subsequently become meaningful users of CEHRT, can qualify for financial incentives. The\nC", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0023", "char_start": 24150, "char_end": 25350, "pages": [9], "text": " implement, or upgrade certified EHR technology\n(CEHRT) and subsequently become meaningful users of CEHRT, can qualify for financial incentives. The\nCenters for Medicare and Medicaid Services (CMS) is dedicated to improving interoperability and patient access\nto health information. The NY Medicaid EHR Incentive Program is a part of the CMS Promoting Interoperability\nProgram, but will continue to operate under the current name, NY Medicaid EHR Incentive Program.\nUpdated Payment Year (PY) 2019 Program Deadlines\nTo allow providers the opportunity to focus on patient care during this difficult time, the NY Medicaid EHR\nIncentive Program has extended all program deadlines for PY 2019 by one month. The new PY 2019 deadlines\nare as follows:\n• PY 2019 Attestation Deadline - June 4, 2020\n• Attestation Deadline Extension (ADE) Request Period Begins - May 20, 2020\n• ADE Request Period End (Last Day to Submit ADE) - June 22, 2020\n• Final PY 2019 Attestation Submission Deadline with Approved ADE - July 8, 2020\nAttestation Deadline Extension (ADE)\nThe ADE Request Period is now open. Providers that are unable to complete their attestation by the deadline\nof June 4, 2020 may be granted an ADE upon", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0024", "char_start": 25200, "char_end": 26400, "pages": [9], "text": "The ADE Request Period is now open. Providers that are unable to complete their attestation by the deadline\nof June 4, 2020 may be granted an ADE upon request. To submit an ADE Request, providers must fill out the\nADE template which requires basic personal information and a reason for the request. The template is available\nfor download at: https://www.health.ny.gov/health_care/medicaid/redesign/ehr/repository/docs/attestation_\next.xls. Completed templates should be sent to attestation@health.ny.gov for review.\nProviders should contact the NY Medicaid EHR Incentive Program support desk with any questions or concerns\nregarding the new deadlines or the ADE process. The support desk is still operating during normal business\nhours and the contact information is available in the Questions section below.\nProgram Discussion Webinars\nThe NY Medicaid EHR Incentive Program will be hosting quarterly Program Discussion Webinars on a variety of\ntopics identified by support staff and the provider community. Providers who would like to submit a particular\ntopic for discussion may do so via the Program Satisfaction Survey available at: https://www.surveymonkey.com\n/r/NY_EHR.\nThe schedule and regist", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0025", "char_start": 26250, "char_end": 27450, "pages": [9, 10], "text": "cular\ntopic for discussion may do so via the Program Satisfaction Survey available at: https://www.surveymonkey.com\n/r/NY_EHR.\nThe schedule and registration information for all webinars, including Program Discussions, Stage 3, Security\nRisk Analysis, Public Health Reporting, Patient Engagement, and Health Information Exchange can be found at:\nhttps://www.health.ny.gov/health_care/medicaid/redesign/ehr/calendar/.\nLISTSERV Communications\nAs the COVID-19 situation continues to develop and change, additional information and program changes may\nbe announced. The NY Medicaid EHR Incentive Program utilizes a LISTSERV messaging system to quickly\ncommunicate any changes or updates and recommends that providers and administrators subscribe in order to\nbest be kept up to date.\nMay 2020 New York State Medicaid Update pg. 9\n\nInformation and instructions on how to subscribe can be found on the NY Medicaid EHR Incentive Program\nLISTSERV webpage at: https://www.health.ny.gov/health_care/medicaid/redesign/ehr/listserv/index.htm.\nProviders who experience any difficulty when attempting to subscribe should contact the support team for\nassistance.\nCheck Participation Status\nAt minimum*, a provider must", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0026", "char_start": 27300, "char_end": 28500, "pages": [10], "text": "ce any difficulty when attempting to subscribe should contact the support team for\nassistance.\nCheck Participation Status\nAt minimum*, a provider must have completed and received an incentive payment for one payment year in PY\n2016 or earlier to participate for future years. Providers uncertain about their participation status are encouraged\nto reach out to the NY Medicaid EHR Incentive Program support team for assistance. Program participation\nstatus can be verified and reviewed using the provider’s National Provider Identifier (NPI) and may assist in\ndetermining a provider’s ability to attest in PY2019-2021. Providers who wish to check their participation status\nshould contact the support team at (877) 646-5410 (Option 2) or via email at: hit@health.ny.gov.\n*Providers must also meet all other relevant program requirements and metrics to be eligible to participate in the NY Medicaid EHR\nIncentive Program.\nNew York State (NYS) Regional Extension Centers (RECs)\nNYS RECs offer free support to help providers achieve Meaningful Use (MU) of CEHRT. Support provided\nby NYS RECs includes, but is not limited to, the following:\n• Answers to questions regarding the program and requirements\n• ", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0027", "char_start": 28350, "char_end": 29550, "pages": [10], "text": "f CEHRT. Support provided\nby NYS RECs includes, but is not limited to, the following:\n• Answers to questions regarding the program and requirements\n• Assistance on selecting and using CEHRT\n• Help meeting program objectives\nNYS RECs offer free assistance for all practices and providers located within New York.\nFor Providers Located:\nInside the five boroughs of NYC Outside the five boroughs of NYC\nContact: Contact:\nNYC REACH New York eHealth Collaborative (NYeC)\nPhone: (347) 396-4888 Phone: (646) 817-4101\nWebsite: https://www.nycreach.org Website: http://www.nyehealth.org\nMU Direct: https://www.nycreach.org/qi-services/ MU Direct: https://www.nyehealth.org/services/\n#meaningful-use meaningful-use\nEmail: nycreach@health.nyc.gov Email: ep2info@nyehealth.org\nQuestions\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at\n(877) 646-5410 (Option 2) or via email at hit@health.ny.gov.\nPlease Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey\nThe NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\n******************************************", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0028", "char_start": 29400, "char_end": 30600, "pages": [10, 11], "text": "entive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\n*******************************************************************************************************************\nMay 2020 New York State Medicaid Update pg. 10\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud or abuse complaints/allegations, call 1-877-87FRAUD, (877) 873-7283, or visit:\nwww.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at https://www.emedny.org/.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nTo sign up for a provider seminar, please enroll online at https://www.emedny.org/training/index.aspx. For\nindividual training requests, call (800) 343-9000.\nBeneficiary Eligibility:\nCall the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current inform", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0029", "char_start": 30450, "char_end": 31441, "pages": [11], "text": "Beneficiary Eligibility:\nCall the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following websites:\n• http://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-educationprog\n• http://nypep.nysdoh.suny.edu/home\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit: https://www.emedny.org\n/info/ProviderEnrollment/index.aspx and choose the appropriate link based on provider type.\nNY Medicaid Electronic Health Record (EHR) Incentive Program\nContact the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nMay 2020 New York State Medicaid Update pg. 11", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0030", "char_start": 31291, "char_end": 31441, "pages": [11], "text": "Regarding This Publication\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nMay 2020 New York State Medicaid Update pg. 11", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0031::table", "char_start": null, "char_end": null, "pages": [4], "text": "\"\"\r\nThe Enacted 2020-2021 State Budget and Medicaid Redesign Team II (MRTII) initiative will decrease Medicaid\r\n\"Taxi/Livery base and mileage fees by 7.5 percent effective June 1, 2020. The updated fees effective for dates\"\r\n\"of service on or after June 1, 2020 are posted at: https://www.emedny.org/ProviderManuals/Transportation/\"\r\nindex.aspx.\r\n\"\"\r\nQuestions\r\n\"Questions regarding this policy should be directed to the Office of Health Insurance Programs (OHIP), Bureau\"\r\nof Medicaid Transportation at (518) 473-2160 or medtrans@health.ny.gov.\r\n\"\"\r\n*******************************************************************************************************************\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0032::table", "char_start": null, "char_end": null, "pages": [5], "text": "\"\"\r\n*******************************************************************************************************************\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0033::table", "char_start": null, "char_end": null, "pages": [5], "text": "NYS Medicaid Fee-for-Service Policy and Billing Guidance for,,,,\r\ncrizanlizumab-tmca (ADAKVEO,,®,\"), New Coverage Criteria and “J” Code\",\r\n,,,,\r\n\"Effective July 1, 2020, New York State (NYS) Medicaid fee-for-service (FFS) will begin utilizing criteria to\",,,,\r\ndetermine the approval of crizanlizumab-tmca (ADVAKVEO®) for members with sickle cell disease to reduce,,,,\r\nthe frequency of vasoocclusive crises when the member meets the criteria outlined in this policy.,,,,ADAKVEO®\r\n\"was approved by the U.S. Food and Drug Administration (FDA) for use on November 15, 2019.\",,,,\r\n,,,,\r\nNYS FFS Coverage Policy,,,,\r\n\"In accordance with FDA indications, FFS will reimburse for ADVAKVEO® when the following criteria are met:\",,,,\r\n,• The patient must have a confirmed diagnosis of sickle cell disease,,,\r\n,• The patient must be sixteen (16) years of age and older,,,\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0034::table", "char_start": null, "char_end": null, "pages": [5], "text": "\"\"\r\nReminders\r\nProviders are reminded that any off-invoice discounts or rebates received from the manufacturer must be passed\r\nback to Medicaid. Storage and handling charges are included in the APG outpatient payment and will not be\r\nreimbursed separately.\r\n\"\"\r\nMedicaid Managed Care (MMC) Billing\r\nProviders participating in MMC should check with the individual health plans to determine their billing policies\r\nand how each MMC plan will apply this FFS policy.\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0035::table", "char_start": null, "char_end": null, "pages": [6], "text": "Questions:,\r\n,• FFS claim questions should be directed to the eMedNY call center at (800) 343-9000.\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0036::table", "char_start": null, "char_end": null, "pages": [6], "text": ",Code,,,Fee,,,Max Unit/Frequency,\r\nA4670,,,$50.00,,,1 every 5 years,,\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0037::table", "char_start": null, "char_end": null, "pages": [7], "text": ",DOSE OPTIMIZATION CHART,,,,,,,,,,\r\n,CARDIOVASCULAR AGENTS,,,,,,,,,,\r\n,Antiarrhythmics,,,,,,,,,,\r\n,\"Drug Name, Strength\",,Dose Optimization Limitations,,,,,,,,\r\namiodarone 100mg,,,1 daily,,,Tablet,,,,\"In case of dose titration for these medications, the\",\r\n,,,,,,,,,,Department will allow for multi-day dosing (up to 2,\r\n,amiodarone 100mg,,,,,,,,,doses/daily) for loading dose for 30 days,\r\n,CENTRAL NERVOUS SYSTEM AGENTS,,,,,,,,,,\r\n,Anticonvulsants,,,,,,,,,,\r\n,\"Drug Name, Strength\",,Dose Optimization Limitations,,,,,,,,\r\n,\"Aptiom® 200mg, 400mg\",,,1 daily,,,Tablet,,,,\r\n,\"Fycompa® 4mg, 6mg\",,,1 daily,,,Tablet,,,,\r\n,topiramate ER 100mg,,,1 daily,,,Capsule,,,,\r\nLamictal XR® 50mg,,,1 daily,,,Tablet,,,,\"In case of dose titration for these medications, the\",\r\n,,,,,,,,,,Department will allow for multi-day dosing (up to 2,\r\n,,,,,,,,,,doses/daily) for titration purposes for 90 days,\r\nOxtellar XR® 300mg,,,1 daily,,,Tablet,,,,\"In case of dose titration for these medications, the\",\r\n,,,,,,,,,,Department will allow for multi-day dosing (up to 2,\r\n,Oxtellar XR® 300mg,,,,,,,,,doses/daily) for titration purposes for 90 days,\r\n,Central Nervous System (CNS) Stimulants,,,,,,,,,,\r\n,\"Drug Name, Strength\",,Dose Optimization Limitations,,,,,,,,\r\n,\"Vyvanse® 10mg, 40mg\",,,1 daily,,,Capsule,,,,\r\n,GASTROINTESTINAL AGENTS,,,,,,,,,,\r\n,Proton Pump Inhibitors,,,,,,,,,,\r\n,\"Drug Name, Strength\",,Dose Optimization Limitations,,,,,,,,\r\n,\"Nexium® 10mg, 20mg\",,1 daily,,,Packet,,,,,\r\n,HEMATOLOGIC AGENTS,,,,,,,,,,\r\n,Anticoagulants – Oral,,,,,,,,,,\r\n,\"Drug Name, Strength\",,Dose Optimization Limitations,,,,,,,,\r\n,Xarelto® 10mg,,,1 daily,,,Tablet,,,,\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0038::table", "char_start": null, "char_end": null, "pages": [9], "text": ",Number of Payments:,,,Distributed Funds:,\r\n\"43,558\",,,\"$1,010,583,699\",,\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0039::table", "char_start": null, "char_end": null, "pages": [10], "text": "For Providers Located:,,,,,\r\n,Inside the five boroughs of NYC,,,Outside the five boroughs of NYC,\r\n\"Contact:\nNYC REACH\nPhone: (347) 396-4888\nWebsite: https://www.nycreach.org\nMU Direct: https://www.nycreach.org/qi-services/\n#meaningful-use\nEmail: nycreach@health.nyc.gov\",,,\"Contact:\nNew York eHealth Collaborative (NYeC)\nPhone: (646) 817-4101\nWebsite: http://www.nyehealth.org\nMU Direct: https://www.nyehealth.org/services/\nmeaningful-use\nEmail: ep2info@nyehealth.org\",,\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0040::table", "char_start": null, "char_end": null, "pages": [10], "text": "Questions\r\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at\r\n(877) 646-5410 (Option 2) or via email at hit@health.ny.gov.\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no10_may20.pdf", "chunk_id": "mu_no10_may20.pdf::0041::table", "char_start": null, "char_end": null, "pages": [10], "text": ",Please Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey,\r\n\"The NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\",,\r\n", "chunk_type": "table", "category": "Medicaid Update"}
